These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 18035867)
1. Comparative safety of long-acting inhaled bronchodilators: a cohort study using the UK THIN primary care database. Jara M; Lanes SF; Wentworth C; May C; Kesten S Drug Saf; 2007; 30(12):1151-60. PubMed ID: 18035867 [TBL] [Abstract][Full Text] [Related]
2. Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease. Chong J; Karner C; Poole P Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD009157. PubMed ID: 22972134 [TBL] [Abstract][Full Text] [Related]
3. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease. Farne HA; Cates CJ Cochrane Database Syst Rev; 2015 Oct; (10):CD008989. PubMed ID: 26490945 [TBL] [Abstract][Full Text] [Related]
4. Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease. Karner C; Cates CJ Cochrane Database Syst Rev; 2012 Apr; 4(4):CD008989. PubMed ID: 22513969 [TBL] [Abstract][Full Text] [Related]
5. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Aaron SD; Vandemheen KL; Fergusson D; Maltais F; Bourbeau J; Goldstein R; Balter M; O'Donnell D; McIvor A; Sharma S; Bishop G; Anthony J; Cowie R; Field S; Hirsch A; Hernandez P; Rivington R; Road J; Hoffstein V; Hodder R; Marciniuk D; McCormack D; Fox G; Cox G; Prins HB; Ford G; Bleskie D; Doucette S; Mayers I; Chapman K; Zamel N; FitzGerald M; Ann Intern Med; 2007 Apr; 146(8):545-55. PubMed ID: 17310045 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial. Hanania NA; Boota A; Kerwin E; Tomlinson L; Denis-Mize K Drugs; 2009 Jun; 69(9):1205-16. PubMed ID: 19537837 [TBL] [Abstract][Full Text] [Related]
7. Ten years of tiotropium: clinical impact and patient perspectives. Yohannes AM; Connolly MJ; Hanania NA Int J Chron Obstruct Pulmon Dis; 2013; 8():117-25. PubMed ID: 23515335 [TBL] [Abstract][Full Text] [Related]
8. Tiotropium versus salmeterol for the prevention of exacerbations of COPD. Vogelmeier C; Hederer B; Glaab T; Schmidt H; Rutten-van Mölken MP; Beeh KM; Rabe KF; Fabbri LM; N Engl J Med; 2011 Mar; 364(12):1093-1103. PubMed ID: 21428765 [TBL] [Abstract][Full Text] [Related]
9. Cardio- and cerebrovascular safety of indacaterol vs formoterol, salmeterol, tiotropium and placebo in COPD. Worth H; Chung KF; Felser JM; Hu H; Rueegg P Respir Med; 2011 Apr; 105(4):571-9. PubMed ID: 21227674 [TBL] [Abstract][Full Text] [Related]
10. Long-acting beta 2-adrenoceptor agonists or tiotropium bromide for patients with COPD: is combination therapy justified? Tennant RC; Erin EM; Barnes PJ; Hansel TT Curr Opin Pharmacol; 2003 Jun; 3(3):270-6. PubMed ID: 12810191 [TBL] [Abstract][Full Text] [Related]
11. A US database study characterizing patients initiating a budesonide-formoterol combination versus tiotropium bromide as initial maintenance therapy for chronic obstructive pulmonary disease. Kern DM; Williams SA; Tunceli O; Wessman C; Zhou S; Pethick N; Elhefni H; Trudo F Int J Chron Obstruct Pulmon Dis; 2014; 9():775-83. PubMed ID: 25071369 [TBL] [Abstract][Full Text] [Related]
12. Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma: The BELT Randomized Clinical Trial. Wechsler ME; Yawn BP; Fuhlbrigge AL; Pace WD; Pencina MJ; Doros G; Kazani S; Raby BA; Lanzillotti J; Madison S; Israel E; JAMA; 2015 Oct; 314(16):1720-30. PubMed ID: 26505596 [TBL] [Abstract][Full Text] [Related]
13. The role of long-acting bronchodilators in the management of stable COPD. Tashkin DP; Cooper CB Chest; 2004 Jan; 125(1):249-59. PubMed ID: 14718448 [TBL] [Abstract][Full Text] [Related]
14. Long-Acting Bronchodilator Initiation in COPD and the Risk of Adverse Cardiopulmonary Events: A Population-Based Comparative Safety Study. Suissa S; Dell'Aniello S; Ernst P Chest; 2017 Jan; 151(1):60-67. PubMed ID: 27554300 [TBL] [Abstract][Full Text] [Related]
15. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD. Keam SJ; Keating GM Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163 [TBL] [Abstract][Full Text] [Related]
16. Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments. Trudo F; Kern DM; Davis JR; Tunceli O; Zhou S; Graham EL; Strange C; Williams SA Int J Chron Obstruct Pulmon Dis; 2015; 10():2055-66. PubMed ID: 26451101 [TBL] [Abstract][Full Text] [Related]
17. Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease. Welsh EJ; Cates CJ; Poole P Cochrane Database Syst Rev; 2013 May; 2013(5):CD007891. PubMed ID: 23728670 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of once-daily indacaterol 75 μg relative to alternative bronchodilators in COPD: a study level and a patient level network meta-analysis. Cope S; Zhang J; Williams J; Jansen JP BMC Pulm Med; 2012 Jun; 12():29. PubMed ID: 22732017 [TBL] [Abstract][Full Text] [Related]
19. Tiotropium bromide: a novel once-daily anticholinergic bronchodilator for the treatment of COPD. Hansel TT; Barnes PJ Drugs Today (Barc); 2002 Sep; 38(9):585-600. PubMed ID: 12582447 [TBL] [Abstract][Full Text] [Related]